Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

526.19 7.58 −1.42%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
7 5 5 6

+8 more TTM periods

ROE
29.14% 27.11% 25.60% 25.28%
ROA
16.90% 16.68% 15.93% 16.54%
ROIC
22.10% 23.46% 22.23% 23.36%
Return on Tangible Assets
112.17% 152.87% 161.98% 119.94%
Average Days of Receivables
34.96 26.53 30.96 26.34
Free Cash Flow per Share
22.73 24.91 27.91 22.92
Free Cash Flow
296.76 328.12 381.71 330.05
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026